(SVRA) Savara - Performance -50.9% in 12m
SVRA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
6.53%
#38 in Peer-Group
Rel. Strength
9.26%
#6739 in Stock-Universe
Total Return 12m
-50.86%
#131 in Peer-Group
Total Return 5y
7.04%
#40 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 5.07 USD |
| 52 Week Low | 1.94 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 54.97 |
| Buy/Sell Signal +-5 | -0.57 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: SVRA (-50.9%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: SVRA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SVRA
| Total Return (including Dividends) | SVRA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -5.00% | 2.09% | 4.55% |
| 3 Months | -17.69% | 2.27% | 10.78% |
| 12 Months | -50.86% | -10.84% | 14.71% |
| 5 Years | 7.04% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | SVRA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -62.5% | 18.8% | 79.2% |
| 3 Months | -63.1% | 71.5% | 92.9% |
| 12 Months | -88.1% | -84.3% | 44.2% |
| 5 Years | 73.2% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th47.50 | -6.94% | -9.14% |
| 3 Month | %th21.00 | -19.51% | -25.70% |
| 12 Month | %th35.50 | -44.89% | -57.16% |
| 5 Years | %th80.50 | 45.13% | -49.63% |
FAQs
Does Savara (SVRA) outperform the market?
No,
over the last 12 months SVRA made -50.86%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months SVRA made -17.69%, while XBI made 2.27%.
Performance Comparison SVRA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SVRA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.6% | -9.6% | -31.8% | -66% |
| US NASDAQ 100 | QQQ | 1.8% | -10.6% | -33.9% | -66% |
| German DAX 40 | DAX | 2.8% | -5% | -44.7% | -81% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3% | -9.2% | -29.8% | -68% |
| Hongkong Hang Seng | HSI | 3% | -10.8% | -47.5% | -86% |
| India NIFTY 50 | INDA | 3% | -7.1% | -31.5% | -51% |
| Brasil Bovespa | EWZ | 1.3% | -12.8% | -56.3% | -64% |
SVRA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.1% | -11.8% | -38.4% | -80% |
| Consumer Discretionary | XLY | 4.2% | -6.6% | -23.1% | -71% |
| Consumer Staples | XLP | 6.1% | -3.4% | -30% | -60% |
| Energy | XLE | 7% | -8.5% | -26.3% | -47% |
| Financial | XLF | 2.5% | -8.1% | -34.9% | -80% |
| Health Care | XLV | 3.6% | -7% | -24.6% | -45% |
| Industrial | XLI | 3% | -8.7% | -38.4% | -75% |
| Materials | XLB | 4.6% | -6.6% | -31.1% | -54% |
| Real Estate | XLRE | 7.1% | -5% | -29.2% | -63% |
| Technology | XLK | 1.3% | -13.9% | -35% | -63% |
| Utilities | XLU | 5% | -5.1% | -35.1% | -75% |
| Aerospace & Defense | XAR | 0.7% | -14.9% | -53.2% | -104% |
| Biotech | XBI | 4.8% | -7.1% | -17.8% | -40% |
| Homebuilder | XHB | 4.4% | -11.1% | -20.5% | -52% |
| Retail | XRT | 5.7% | -6.4% | -23.1% | -57% |
SVRA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 9.9% | -10.1% | -22.5% | -41% |
| Natural Gas | UNG | 14.8% | 4.4% | -16.6% | -43% |
| Gold | GLD | 7.6% | -2.8% | -51.6% | -92% |
| Silver | SLV | 6% | -8.9% | -50.3% | -73% |
| Copper | CPER | 2.3% | -9.2% | -51.5% | -66% |
SVRA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.9% | -8.6% | -28.6% | -53% |
| iShares High Yield Corp. Bond | HYG | 4.7% | -6.9% | -30.8% | -62% |